title: Medical treatment of severe hyperparathyroidism and its influence on anaemia in end-stage renal failure.
authors.affiliation: Centre de Recherche Biochimie Macromoléculaire (CRBM), CNRS LP 9008-INSERM Unit 249, University of Montpellier I, France.
authors.forename: A
authors.initials: A
authors.lastname: Argilés
authors.forename: G
authors.initials: G
authors.lastname: Mourad
authors.forename: R
authors.initials: R
authors.lastname: Lorho
authors.forename: P G
authors.initials: PG
authors.lastname: Kerr
authors.forename: J L
authors.initials: JL
authors.lastname: Flavier
authors.forename: B
authors.initials: B
authors.lastname: Canaud
authors.forename: C M
authors.initials: CM
authors.lastname: Mion
mesh_terms: D000328:Adult; D000368:Aged; D000740:Anemia / Q000188:drug therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use; D006961:Hyperparathyroidism / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D006454:Hemoglobins; D006887:Hydroxycholecalciferols; D004921:Erythropoietin; C008088:alfacalcidol